166 related articles for article (PubMed ID: 28401701)
1. Presence of bone marrow micro-metastases in stage I-III colon cancer patients is associated with worse disease-free and overall survival.
Viehl CT; Weixler B; Guller U; Dell-Kuster S; Rosenthal R; Ramser M; Banz V; Langer I; Terracciano L; Sauter G; Oertli D; Zuber M
Cancer Med; 2017 May; 6(5):918-927. PubMed ID: 28401701
[TBL] [Abstract][Full Text] [Related]
2. Comparative Analysis of Tumor Cell Dissemination to the Sentinel Lymph Nodes and to the Bone Marrow in Patients With Nonmetastasized Colon Cancer: A Prospective Multicenter Study.
Weixler B; Viehl CT; Warschkow R; Guller U; Ramser M; Sauter G; Zuber M
JAMA Surg; 2017 Oct; 152(10):912-920. PubMed ID: 28593306
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow micrometastases do not impact disease-free and overall survival in early stage sentinel lymph node-negative breast cancer patients.
Langer I; Guller U; Worni M; Berclaz G; Singer G; Schaer G; Fehr MK; Hess T; Viehl C; Bronz L; Schnarwyler B; Wight E; Infanger E; Burger D; Koechli OR; Zuber M;
Ann Surg Oncol; 2014 Feb; 21(2):401-7. PubMed ID: 24145993
[TBL] [Abstract][Full Text] [Related]
4. The Simultaneous Presence of Isolated Tumour Cells and Bone Marrow Micrometastases in Stage I and II Colon Cancer-Challenging the Theory of a Chronological Pathway of Tumour Cell Dissemination.
Ramser M; Warschkow R; Viehl CT; Kettelhack C; Zettl A; Lobbes LA; Zuber M; Weixler B
World J Surg; 2022 Mar; 46(3):680-689. PubMed ID: 34958413
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of bone marrow micrometastasis in patients with operable esophageal squamous cell carcinoma: a long-term follow-up study.
Chen SB; Su XD; Ma GW; Lin P; Wen J; Wang FX; Zhang H; Fu JH; Zhang X
J Thorac Oncol; 2014 Aug; 9(8):1207-13. PubMed ID: 25157775
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
[TBL] [Abstract][Full Text] [Related]
7. The impact of bone marrow micrometastases on metastatic disease-free survival in patients with colorectal carcinoma.
O'Connor OJ; Cahill RA; Kirwan WO; Redmond HP
Colorectal Dis; 2005 Jul; 7(4):406-9. PubMed ID: 15932568
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer.
Hsu CP; Shen GH; Ko JL
Lung Cancer; 2006 Jun; 52(3):349-57. PubMed ID: 16569461
[TBL] [Abstract][Full Text] [Related]
9. Pathomics Signature for Prognosis and Chemotherapy Benefits in Stage III Colon Cancer.
Jiang W; Wang H; Dong X; Yu X; Zhao Y; Chen D; Yan B; Cheng J; Zhuo S; Wang H; Yan J
JAMA Surg; 2024 May; 159(5):519-528. PubMed ID: 38416471
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic Role of Mismatch Repair Status and CDX-2 Expression with Inflammatory Markers and Pathological Risk Factors in Stage II and III Colon Cancer: Multicenter Real-Life Data.
Aydin SG; Olmez OF; Selvi O; Geredeli C; Ozden F; Bilici A; Acikgoz O; Karci E; Kutlu Y; Hamdard J; Aydin A
J Gastrointest Cancer; 2024 Mar; 55(1):227-236. PubMed ID: 37347353
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of bone marrow micrometastases with sentinel lymph node status in early-stage breast cancer.
Saha S; Ali S; Ghanem M; Soni M; Wiese D; Arora M; Singh T; Iddings D
Ann Surg Oncol; 2009 Feb; 16(2):276-80. PubMed ID: 19050967
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.
André T; de Gramont A; Vernerey D; Chibaudel B; Bonnetain F; Tijeras-Raballand A; Scriva A; Hickish T; Tabernero J; Van Laethem JL; Banzi M; Maartense E; Shmueli E; Carlsson GU; Scheithauer W; Papamichael D; Möehler M; Landolfi S; Demetter P; Colote S; Tournigand C; Louvet C; Duval A; Fléjou JF; de Gramont A
J Clin Oncol; 2015 Dec; 33(35):4176-87. PubMed ID: 26527776
[TBL] [Abstract][Full Text] [Related]
13. Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy.
Kim JE; Hong YS; Kim HJ; Kim KP; Lee JL; Park SJ; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Hoon KJ; Kim TW
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S630-7. PubMed ID: 26271397
[TBL] [Abstract][Full Text] [Related]
14. Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
Meyerhardt JA; Sato K; Niedzwiecki D; Ye C; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Wigler DS; Venook A; Fuchs CS
J Natl Cancer Inst; 2012 Nov; 104(22):1702-11. PubMed ID: 23136358
[TBL] [Abstract][Full Text] [Related]
15. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow micrometastasis is associated with both disease recurrence and poor survival in surgical patients with node-negative non-small-cell lung cancer: a meta-analysis.
Deng XF; Liu QX; Zhou D; Min JX; Dai JG
Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):21-7. PubMed ID: 25883247
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of bone marrow microinvolvement in nonsmall cell lung carcinoma.
Hsu CP; Shai SE; Hsia JY; Chen CY
Cancer; 2004 Feb; 100(4):794-800. PubMed ID: 14770436
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study.
Kim SH; Shin SJ; Lee KY; Kim H; Kim TI; Kang DR; Hur H; Min BS; Kim NK; Chung HC; Roh JK; Ahn JB
Ann Surg Oncol; 2013 Oct; 20(11):3407-13. PubMed ID: 23943026
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic value and initial exploratory research on TNM staging method of tumor deposits in stage III colon cancer].
Qin Q; Yang L; Zhou AP; Wang JW; Zhong DS
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1152-1158. PubMed ID: 31874531
[No Abstract] [Full Text] [Related]
20. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
Braun S; Pantel K; Müller P; Janni W; Hepp F; Kentenich CR; Gastroph S; Wischnik A; Dimpfl T; Kindermann G; Riethmüller G; Schlimok G
N Engl J Med; 2000 Feb; 342(8):525-33. PubMed ID: 10684910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
